Articles written by: Eric Painter

Position decreased In Zogenix, Inc By Matt Sirovich And Jeremy Mindich’s Scopia Capital Management Lp

Position decreased In Zogenix, Inc By Matt Sirovich And Jeremy Mindich’s Scopia Capital Management Lp

Matt Sirovich And Jeremy Mindich’s Scopia Capital Management Lp posted reduced Interest in Zogenix, Inc Scopia Capital Management Lp filed with SEC a SC 13G/A form about Zogenix, Inc. The form can be accessed here: 000089109219000537.The filler decreased its stake in the stock by -77.72 % for 2,985,834 shares.In another […]

Far East Fame Line DDB Public Company Limited (FE) Moves Up 0.58% on Jan 11

Shares of Far East Fame Line DDB Public Company Limited (BKK:FE) last traded at 173, representing a move of 0.58%, or 1 per share, on volume of 100 shares. After opening the trading day at 173, shares of Far East Fame Line DDB Public Company Limited traded in a close […]

Inrad Optics, Inc’s Price Jumped After Stake increased By Nicklin V Adah

Inrad Optics, Inc’s Price Jumped After Stake increased By Nicklin V Adah

The increased Interest in Inrad Optics, Inc was posted by Nicklin V Adah Nicklin V Adah filed with SEC a SC 13G/A form about Inrad Optics, Inc. The form can be accessed here: 000108514619000120.The filler increased its position in the stock by 100.00 % for 827,580 shares.In another report on […]

Puma Biotechnology Inc (NASDAQ:PBYI) Shorts Reduced By 19.25% As Of Jan 11, 2019

Puma Biotechnology Inc (NASDAQ:PBYI) Shorts Reduced By 19.25% As Of Jan 11, 2019

During Q3 2018 the big money sentiment decreased to 0.99. That’s change of 0.33, from 2018Q2’s 1.32. 29 investors sold all, 39 reduced holdings as Puma Biotechnology, Inc. ratio is negative. 48 grew holdings while 19 funds bought holdings. Funds hold 33.41 million shares thus 10.98% less from 2018Q2’s 37.53 […]

Dexcom Inc – Jpmorgan Chase & Co Reported Position

Dexcom Inc – Jpmorgan Chase & Co Reported Position

During Q3 2018 the big money sentiment increased to 1.31. That’s change of 0.09, from 2018Q2’s 1.22. 12 investors sold all, 107 reduced holdings as DexCom, Inc. ratio increased. 72 increased holdings while 84 funds bought holdings. Funds hold 84.12 million shares thus 4.99% less from 2018Q2’s 88.54 million shares. […]